|
Variables
|
AF patients (n = 80)
|
Healthy controls (n = 20)
|
P-value
|
|---|
|
LAV, mL
|
122 ± 32
|
103 ± 11
|
< 0.001
|
|
LVEF, %
|
62 ± 9
|
66 ± 7
|
0.051
|
|
LVEDV, mL
|
123 ± 26
|
120 ± 27
|
0.708
|
|
LVESV, mL
|
47 ± 12
|
41 ± 13
|
0.027
|
|
LV SV, mL
|
76 ± 16
|
79 ± 18
|
0.594
|
|
LV mass, g
|
130 ± 35
|
122 ± 33
|
0.118
|
|
LV peak SCS (%)
|
− 18.2 ± 2.0
|
− 21.9 ± 1.1
|
< 0.001
|
|
LV peak SCS rate (s− 1)
|
− 1.15 ± 0.16
|
− 1.21 ± 0.03
|
< 0.001
|
|
LV early DCS rate (s− 1)
|
1.20 ± 0.18
|
1.35 ± 0.13
|
< 0.001
|
|
LV LGE
|
0
|
–
|
–
|
|
LV native T1 time, ms
|
1280 ± 33
|
1251 ± 12
|
< 0.001
|
- Data are expressed as mean ± SD
- CMR cardiovascular magnetic resonance, AF atrial fibrillation, LV left ventricle/left ventricular, LAV left atrium volume, LVEF left ventricular ejection fraction, LVEDV left ventricular end-diastolic volume, LVESV left ventricular end-systolic volume, SV stroke volume, SCS systolic circumferential strain, DCS diastolic circumferential strain, LGE late gadolinium enhancement
